Henipaviruses hijack a mechanism used by cells to counter DNA damage and prevent harmful mutations, important in diseases such as cancer.
Monash University's Biomedicine Discovery Institute (BDI) researchers have developed a novel mechanism used by Henipaviruses in infection and potential new targets for antivirals to treat the deadliest viral infection. Their findings may also apply to other dangerous viruses. The research was published today in Nature Communications. Dr Moseley said it was already known that the viruses send a particular protein into a key part of a cell's nucleus called the nucleolus, but it wasn't known why it did this.
‘Henipaviruses including Hendra, lethal to humans and horses, and the Nipah virus, a serious threat in East and Southeast Asia are on the WHO Blueprint list of priority diseases needing urgent research and development action.’
He said the researchers showed that this protein interacted with a cell protein that is an important part of the DNA-damage response machinery, called 'Treacle'. This inhibited Treacle function, which appears to enhance henipavirus production. (Treacle is, incidentally, involved in a craniofacial disorder called Treacher Collins syndrome, aired in the popular US movie Wonder in 2017.)
"What the virus seems to be doing is imitating part of the DNA damage response," Dr Moseley said.
"It is using a mechanism your cells have to protect you against things like ageing and mutations that lead to cancer. This appears to make the cell a better place for the virus to prosper," he said.
According to Dr Moseley, it is possible that blocking the virus from doing this may lead to the development of new anti-viral therapies.
Advertisement
Advertisement
"Like Ebola, if you get a really big outbreak and it's not containable, it could be disastrous," he said.
He said the study's findings add insights into how viruses behave more generally.
"We identified a new way that viruses change the cell, by using the very same machinery that the cell normally uses to protect itself from diseases like cancer," he said.
"This seems to be heading towards exciting possibilities about what viruses might be doing," joint first author, Dr Stephen Rawlinson said.
"We are now trying to work out exactly how changing the DNA damage response through Treacle is useful to this and other dangerous viruses," he said.
Source-Eurekalert